All In MedTech

Device Trial Radar · NCT00351559

IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection

Invasive Monitoring Attenuation Through Gene Expression (IMAGE) Trial

Last checked: Nov 20, 2026Latest source record: Nov 20, 2009 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 629 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

629

Actual

Start

Jan 2005

Primary completion

Not stated

Study completion Oct 2009

Sponsor

Lead sponsor
XDxNot on our public-company list
Sponsor type
Industry
First posted
Jul 13, 2006

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to evaluate the safety and efficacy of a leukocyte gene expression profiling method in the monitoring of asymptomatic heart transplant patients for acute rejection.

Conditions

  • Graft Rejection
  • Heart Diseases

Interventions

  • AlloMap molecular expression testingDevice

  • Right ventricular endomyocardial biopsyProcedure

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time from study enrollment to the earliest date of decrease in left ventricle function (left ventricular ejection fraction [LVEF] decrease ≥ 25% from baseline)
  2. Time from study enrollment to the development of clinically overt rejection (heart failure, hemodynamic compromise)
  3. Time from study enrollment to death from any cause

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • VA Palo Alto Health Care System

    Palo Alto, California

  • Stanford University Medical Center

    Stanford, California

  • Northwestern University

    Chicago, Illinois

10 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.